chr9-32550898-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000360538.7(TOPORS):āc.74C>Gā(p.Ser25Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00986 in 1,612,974 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S25L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000360538.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOPORS | NM_005802.5 | c.74C>G | p.Ser25Trp | missense_variant | 2/3 | ENST00000360538.7 | NP_005793.2 | |
TOPORS | NM_001195622.2 | c.3+1536C>G | intron_variant | NP_001182551.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOPORS | ENST00000360538.7 | c.74C>G | p.Ser25Trp | missense_variant | 2/3 | 1 | NM_005802.5 | ENSP00000353735 | P3 | |
TOPORS | ENST00000379858.1 | c.3+1536C>G | intron_variant | 1 | ENSP00000369187 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00694 AC: 1057AN: 152216Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00825 AC: 2001AN: 242688Hom.: 15 AF XY: 0.00817 AC XY: 1084AN XY: 132680
GnomAD4 exome AF: 0.0102 AC: 14853AN: 1460640Hom.: 100 Cov.: 31 AF XY: 0.0100 AC XY: 7269AN XY: 726682
GnomAD4 genome AF: 0.00693 AC: 1056AN: 152334Hom.: 7 Cov.: 32 AF XY: 0.00713 AC XY: 531AN XY: 74500
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | ENSG00000288684: BS1, BS2; TOPORS: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Aug 24, 2017 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 25, 2014 | - - |
Retinitis pigmentosa 31 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 24, 2021 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at